OverviewChartNewsTraderScreen

BPX/  PLDOMEX00010  /

IDC Poland New Connect
-  - Chg. - Volume Bid- Ask- High Low
-PLN - -
Turnover: -		 -Bid Size: - -Ask Size: - - -
GlobeNewswire 02-06 Weatherford Announces Fourth Quarter and Full Year 2023 Results
GlobeNewswire 2022-03-24 Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire 2022-01-26 Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
GlobeNewswire 2021-12-13 Bellicum Regains Compliance with Nasdaq Continued Listing Requirements
GlobeNewswire 2021-12-06 Bellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Privat...
GlobeNewswire 2021-11-04 Bellicum Reports Third Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire 2021-09-03 Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Confere...
GlobeNewswire 2021-09-01 Bellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety Switch
GlobeNewswire 2021-08-12 Bellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire 2021-07-26 Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2021-06-28 Bellicum Enters License Agreement with UNC Lineberger and Mass General for Use of CaspaCIDe® Safety ...
GlobeNewswire 2021-05-17 Bellicum Reports First Quarter 2021 Financial Results and Provides Operational Update
GlobeNewswire 2021-03-30 Bellicum Reports Fourth Quarter 2020 Financial Results and Provides Operational Update
GlobeNewswire 2021-03-23 Bellicum to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
GlobeNewswire 2021-03-04 Bellicum Announces First Reported Use of CaspaCIDe® Safety Switch to Mitigate CAR-T Cell Toxicity
GlobeNewswire 2021-01-28 Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
GlobeNewswire 2020-12-10 Bellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603
GlobeNewswire 2020-12-07 Bellicum Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial
GlobeNewswire 2020-11-05 Bellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update
GlobeNewswire 2020-11-04 Bellicum Pharmaceuticals Announces Closing of $25.0 Million Underwritten Offering
GlobeNewswire 2020-10-29 Bellicum Announces $25.0 Million Underwritten Offering Priced At-The-Market
GlobeNewswire 2020-10-29 Bellicum Announces Interim BPX-601 Data and Corporate Restructuring
GlobeNewswire 2020-09-30 Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2020-09-28 Bellicum to Participate in Two Upcoming Virtual Conferences
GlobeNewswire 2020-09-15 Timber Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for BPX-01...